Covid 19 death analysis in Colombia

Palabras clave: SARS-CoV-2, COVID-19, Colombia

Resumen

Introduction: This article shows an analysis of the evolution up until date (May 4-2021), of official coronavirus cases statistics (CC) and the total number of deaths (TND) due to SARS-CoV-2 in Colombia. Additionally, said information is shown in correlation to other variables such as Case Fatality Rate (CFR), age range of persons, their typical reported co-morbidities and the cities where there has been highest concentration of cases. Materials and Methods: From March 16 2020 until today, information regarding the daily number of new confirmed cases (DNC) and daily confirmed deaths (DD) was registered in a database with the purpose of estimating the evolution of CC, TND and CFR. The age of deceased was also registered, as well as their gender, prior co-morbidities and city of death. The evolution of TND with the time of other countries were compared to that of Colombia. A mathematical equation that represents the epidemiological curve of TND evolution of different countries across time was defined. Results: In Colombia, the average age of people who die due to COVID-19 is of 69.5±14.7 years (median and mode of 71 and 80 years, respectively), and the virus is less lethal amongst a population under the age of 40. The greater part of deaths have taken place in people with prior co-morbidities and of the male gender. Conclusion: Most of the persons that have deceased are those of senior age, mainly with prior co-morbidities, and predominantly of male gender. Epidemiological peaks of COVID-19 are consistent with the rainy and winter seasons, and with the traditional epidemiological peaks of flu or influenza.

How to cite this Article: Rondón-Quintana Hugo Alexander, Zafra-Mejía Carlos Alfonso. Covid 19 death analysis in Colombia. Revista Cuidarte. 2021;12(3):e.1528 http://dx.doi.org/10.15649/cuidarte.1528

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Hugo Alexander Rondón-Quintana, Universidad Distrital Francisco José de Caldas

Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.

Carlos Alfonso Zafra-Mejía, Universidad Distrital Francisco José de Caldas

Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.

Citas

Gorbalenya AE, Baker SC, Baric RS, Groot RJ, Drosten C, Gulyaeva, AA, Haagmans BL. et al. Severe acute respiratory syndrome-related coronavirus—the species and its viruses, a statement of the coronavirus study group. Nat Microbiol. 2020;5:536–44. https://doi.org/10.1101/2020.02.07.937862

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239-42. https://doi.org/10.1001/jama.2020.2648

Liu Y, Gayle AA, Wilder-Smith A, Rocklov J. The reproductive number of covid-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):1–4. https://doi.org/10.1093/jtm/taaa021

Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020;25(5): 2000062. https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062

Yang Y, Liu MJ, Wang YX, Zhang AR, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. MedRxiv. 2020. https://doi.org/10.1101/2020.02.10.20021675

Xie M, Chen Q. Insight into 2019 novel coronavirus — an updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. 2020;94:119–24. https://doi.org/10.1016/j.ijid.2020.03.071

Alshogran O Y, Altawalbeh, S M, Al-Azzam, S I, Karasneh, R. Predictors of Covid-19 case fatality rate: An ecological study. Ann Med. Surgery, 2021;65:102319. https://doi.org/10.1016/j.amsu.2021.102319

Mazza M G, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni E M T, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594-600. https://doi.org/10.1016/j.bbi.2020.07.037

Khan S, Siddique R, Bai Q, Shabana Y, Xue M, Nabi G, Liu, J. Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options. J Infect Public Heal. 2020. https://doi.org/10.1016/j.jiph.2020.07.010

Khan I, Haleem A, Javaid M. Analysing COVID-19 pandemic through cases, deaths, and recoveries. J Oral Biol Craniofac Res. 2020;10(4):450-69. https://doi.org/10.1016/j.jobcr.2020.08.003

Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, Abosalif K, Ahmed Z, Younas E. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Heal, Available online 4 August 2020:In Press, Corrected Proof. https://doi.org/10.1016/j.jiph.2020.07.014

Mandal CC, Panwar, MS. Can the summer temperatures reduce COVID-19 cases? Public Health, 2020;185:72-9. https://doi.org/10.1016/j.puhe.2020.05.065

Haque SE, Rahman M. Association between temperature, humidity, and COVID-19 outbreaks in Bangladesh. Environ Sci Policy, 2020;114:253-255. https://doi.org/10.1016/j.envsci.2020.08.012

Sartor G, Del Riccio M, Dal Poz I, Bonanni P, Bonaccorsi G. COVID-19 in Italy: Considerations on official data. Int J Infect Dis. 2020;98:188-190. https://doi.org/10.1016/j.ijid.2020.06.060

Departamento Administrativo Nacional de Estadística (DANE). Información Capital. 2019 [Consulted on 1 of May of 2021]. https://www.dane.gov.co/files/varios/informacion-capital-DANE-2019.pdf.

Ministerio de Salud (MINSALUD). Lineamientos para la prevención, diagnóstico, manejo y control de casos de Influenza. 2018 [Consulted on 1 of May of 2021]. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/lineamientos-prevencion-diagnostico-manejo-control-casos-influenza.pdf.

Chowell G, Sattenspiel L, Bansal S, Viboud C. Mathematical models to characterize early epidemic growth: a review. Phys Life Rev. 2016;18:66–97. https://doi.org/10.1016/j.plrev.2016.07.005

De la Hoz-Restrepo F, Alvis-Zakzuk NJ, De la Hoz-Gomez JF, De la Hoz-Gomez A, Gomez Del Corral L, Alvis-Guzmán N. Is Colombia an example of successful containment of the COVID-19 2020 pandemic? A critical analysis of the epidemiological data. March to July 2020. Int J Infect Dis. 2020;99:522-9. https://doi.org/10.1016/j.ijid.2020.08.017

Departamento Administrativo Nacional de Estadística (DANE). Pobreza y desigualdad. 2020 [Consulted on 24 of May of 2020]. https://www.dane.gov.co/index.php/estadisticas-por-tema/pobreza-y-condiciones-de-vida/pobreza-y-desigualdad.

Ministerio de Salud. Desnutrición infantil en Colombia: Marco de referencia. Papeles en Salud Edición No. 03 agosto de 2016 Bogotá D.C. [Consulted on 5 of July of 2020]. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/AS/papeles-salud-n3.pdf

Departamento Administrativo Nacional de Estadística (DANE). Defunciones no fetales. 2019 [Consulted on 5 of July of 2020]. https://www.dane.gov.co/index.php/estadisticas-por-tema/salud/nacimientos-y defunciones/defunciones-no-fetales/defunciones-no-fetales-2019

Departamento Administrativo Nacional de Estadística (DANE). Gran encuesta integrada de hogares (GEIH) Mercado laboral. 2020 [Consulted on 5 of July of 2020]. https://www.dane.gov.co/index.php/estadisticas-por-tema/mercado-laboral/empleo-y-desempleo.

Departamento Administrativo Nacional de Estadística (DANE). Censo Nacional de Población y Vivienda 2018. 2018 [Consulted on 30 of April of 2020]. https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/censo-nacional-de-poblacion-y-vivenda-2018/cuantos-somos

Badawi A, Ryoo SG. Prevalence of comorbidities in the middle east respiratory syndrome coronavirus (MERS-Cov): A systematic review and meta-analysis. Int J Infect Dis. 2016;49:129–33. https://doi.org/10.1016/j.ijid.2016.06.015

Lai C, Shih T, Ko W, Tang H, Hsueh P. Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. https://doi.org/10.1016/j.ijantimicag.2020.105924

Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allerg Immu. 2019;56(3):308–21. https://doi.org/10.1007/s12016-017-8648-x

Bonmarin I, Belchior E, Bergounioux J, Brun-Buisson C, Megarbane B, Chappert J L, et al. Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons. Euro Surveill. 2015;20(46). https://doi.org/10.2807/1560-7917.ES.2015.20.46.30066

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, et al. Severe influenza in 33 US hospitals, 2013-2014: complications and risk factors for death in 507 patients. Infec Control Hosp Epidemiol. 2015;36(11):1251-60. https://doi.org/10.1017/ice.2015.170

Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347: f5061. https://doi.org/10.1136/bmj.f5061

Goeijenbier M, van Sloten T T, Slobbe L, Mathieuf C, van Genderen P, Beyer W, Osterhaus A. Benefits of flu vaccination for persons with diabetes mellitus: a review. Vaccine 2017;35(38):5095–101. https://doi.org/10.1016/j.vaccine.2017.07.095

Zhang ZXZ, Kyaw W, Ho HJ, Tay MZ, et al. Seasonal influenza-associated intensive care unit admission and death in tropical Singapore 2011-2015. J Clin Virol. 2019;117:73-9. https://doi.org/10.1016/j.jcv.2019.06.005

Zou Q, Zheng S, Wang X, Liu S, Bao J, et al. Influenza a-associated severe pneumonia in hospitalized patients: risk factors and NAI treatments. Int J Infect Dis. 2020;92:208-13. https://doi.org/10.1016/j.ijid.2020.01.017

Guerrero N, Yépez-Ch M C. Factores asociados a la vulnerabilidad del adulto mayor con alteraciones de salud [Factors associated with the vulnerability of the elderly with health disorders] Universidad y Salud, 2015;17(1):121-31. http://www.scielo.org.co/pdf/reus/v17n1/v17n1a11.pdf

Al-Qahtani A. Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2): Emergence, history, basic and clinical aspects. Saudi J Biol Sci. 2020;27(10):2531-8. https://doi.org/10.1016/j.sjbs.2020.04.033

Guan W, Ni Z, Yu H, Liang H, Ou C, et al. Clinical characteristics of coronavirus disease 2019 in China. The New England J Med. 2020;382:1708-20. https://doi.org/10.1056/NEJMoa2002032

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020;395:507–13. https://doi.org/10.1016/S0140-6736(20)30211-7

Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 – systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Diseases, 2020;29(8):104949. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104949

Sanchez-Ramirez DC, Mackey, D. Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis. Respir Med. 2020;171:106096. https://doi.org/10.1016/j.rmed.2020.106096

Yadav R, Aggarwal S, Singh A. SARS-CoV-2-host dynamics: Increased risk of adverse outcomes of COVID-19 in obesity. Diabetes Metab Syndr: Clinical Research & Reviews, 2020;14(5):1355-60. https://doi.org/10.1016/j.dsx.2020.07.030

Publicado
2021-08-20
Cómo citar
1.
Rondón-Quintana HA, Zafra-Mejía CA. Covid 19 death analysis in Colombia. Rev Cuid [Internet]. 20 de agosto de 2021 [citado 28 de septiembre de 2021];12(3). Disponible en: https://revistas.udes.edu.co/cuidarte/article/view/1528
Sección
Artículos de Investigación